A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation Compared to Placebo in Adult Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)
The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)